References: Overview of emotional, psychological and behavioural symptoms in palliative care

Black N, Stockings E, Campbell G, Tran LT, Zagic D, Hall WD, et al. Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis. Lancet Psychiatry 2019;6(12):995-1010. https://www.ncbi.nlm.nih.gov/pubmed/31672337
Kelly B, McClement S, Chochinov HM. Measurement of psychological distress in palliative care. Palliat Med 2006;20(8):779-89. https://www.ncbi.nlm.nih.gov/pubmed/17148532
Mucke M, Weier M, Carter C, Copeland J, Degenhardt L, Cuhls H, et al. Systematic review and meta-analysis of cannabinoids in palliative medicine. J Cachexia Sarcopenia Muscle 2018;9(2):220-34. https://www.ncbi.nlm.nih.gov/pubmed/29400010
Therapeutic Goods Administration (TGA). Guidance for the use of medicinal cannabis in the treatment of palliative care patients in Australia. Canberra: TGA. 2017; Accessed 7 Dec 2022. https://www.tga.gov.au/resources/publication/publications/guidance-use-medicinal-cannabis-treatment-palliative-care-patients-australia